A recent study at Sheba Medical Center, Tel Hashomer, also in conjunction with the Israel Cancer Association, shows that more than two-thirds of cancer patients who were prescribed medical marijuana to combat pain are reportedly satisfied with the treatment. The study involved 264 cancer patients treated with medical marijuana for an entire year.
According to the study, around 61 percent of the respondents reported a significant improvement in their quality of life as a result of the medical marijuana, while 56 percent noted an improvement in their ability to manage pain. In general, 67 percent were in favor of the treatment, while 65 percent said they would recommend it to other patients.
Also according to the study, the most common types of cancer for which medical marijuana is prescribed are lung cancer (21 percent ), breast cancer (12 percent ) and pancreatic cancer (10 percent ).